Pediatric Exclusivity: How the FDA Extends Market Protection Without Changing Patents Pediatric exclusivity gives drugmakers six months of extra market protection after they study medicines in children. It doesn't extend patents but blocks generic approval, making it a key tool in pharmaceutical strategy. Nov, 26 2025
